Secondary immune deficiencies and HIV-1 infection Flashcards

1
Q

What are 7 causes of secondary immune deficiencies?

A

Malnutrition (commonest globally)

Infectious Diseases e.g. HIV

Environmental stress

Age Extremes: Prematurity + old age

Surgery + trauma, splenectomy

Immunosuppressive drugs

Genetic + metabolic diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are signs and symptoms of secondary immune deficiencies?

A

Infections: Severe, persistent, recurrent, unusual

Autoimmune conditions (cytopaenias) and allergic disease

Persistent inflammation

Cancer (viral associated EBV, HHV-8)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which small molecules can cause immune deficiencies?

A
  • Glucocorticoids + mineralocorticoids
  • Cytotoxic agents: Methotrexate, mycophenolate, cyclophosphamide + azathioprine.
  • Calcineurin inhibitors: Cyclosporine + tacrolimus
  • Antiepileptic drugs (phenytoin, carbamazepine, levetiracetam)
  • DMARD (sulphasalazine, leflunomide)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which JAK inhibitors can cause immune deficiencies?

A
  • Tofacitinib
  • Upadacitinib
  • Ruxolitinib

Being used in increasing no. diseases e.g. RA, GvHD

Can cause antibody deficiency

A/w increased risk of reactivation of herpes zoster

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which drug class can cause TB reoccurance?

A

Anti-TNF agents

Screen for latent TB

If detected give TB prophylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which cancers can present with secondary immune deficiencies?

A

B + plasma cell cancers (antibody deficiency syndromes are most common).

Chemotherapy, biological agents, + radiotherapy can leads to loss of immune cells + immune deficiency.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which specific B-cell lymphoproliferative disorders are associated with secondary immune deficiency?

A

Multiple myeloma

Chronic lymphocytic leukaemia

Non Hodgkin’s lymphoma

Monoclonal gammopathy of uncertain significance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is Good’s syndrome?

A

Thymoma + antibody deficiency

Combined T + B cell (absent) defect

Increased risk of CMV, PJP + muco-cutaneous candida

As thymus involved in control of central tolerance, increased risk of AI disease (Pure red cell aplasia, Myasthenia gravis, Lichen planus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are appropriate investigations for secondary immune deficiencies?

A

FISH

FBC: Hb < 10g/L, Neutrophil, Lymphocyte + Platelet count

Immunoglobulins: IgG, IgA, IgM, IgE

Serum complement: C3, C4

HIV test: 18-80y

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is serum protein electrophoresis?

A

Separation of serum proteins by charge

Detection of discrete bands: monoclonal identified by immunofixation with labelled IgG, IgA, IgM anti-sera

SPE can miss free light chain disease (seen in 20% multiple myeloma cases): hence measurement of free light chains is essential for work up of B cell LPD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are second line investigations for secondary immune deficiencies?

A

Measure concentration of vaccine antibodies:

  • Tetanus toxoid: Protein antigen
  • Pneumovax vaccine: Carbohydrate antigen (all 23 serotypes or to individual pneumococcal serotypes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are third line investigations for secondary immune deficiencies?

A

Analysis of naïve + memory T + B cell subsets

Assessment of IgG subclasses

Determination of anti-cytokine + complement antibodies

Genetics (whole exome or whole genome sequencing in cases where it is uncertain whether primary or secondary immune defect)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the management of secondary immune deficiencies?

A

Treat underlying cause

Advise on measures to reduce exposure to infection

Immunisation against respiratory viruses + bacteria + offer vaccines to household contacts

Education to treat bacterial infections promptly: May require higher doses + longer courses (co-amoxiclav 625mg TDS for 10-14d rather than 375mg for 5-7d)

Prophylactic abx for confirmed recurrent bacterial infection (>,2/y)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What type of immunodeficiency is more common?

A

Secondary immune deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the secondary immune deficiency caused by measles

A

Immune defect lasts months-years

Increases morbidity + mortality esp. due to secondary bacterial infection/ unexplained diarrhoeal illness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the secondary immune deficiency caused by TB

A

Depresses cell mediated immune response- detected as failed Mantoux test

In tx their immune system reconstitutes, sees infections the patient has experienced + mounts an inflammatory response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the secondary immune deficiency caused by HIV

A

Residual immune dysfunction persists despite successful ART

Increased inflammation, cellular/ soluble markers of immune activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Give an example of a glucocorticoid causing immune deficiency

A

>10mg/day prednisolone linked to increased rate of antibody loss

Affects cellular + humoral immunity

Increased susceptibility to bacterial + viral infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How do calcineurin inhibitors cause immune deficiency?

A

Cause cellular immune deficiency

Target dendritic cells + CD4 follicular function

Impact on peoples ability to respond to vaccines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Name a biologic/ cellular therapy that can cause immune deficiency

A

Rituximab (anti-CD20 antibodies)

Increases risk of antibody deficiency

Increased risk of secondary infection

Increased risk of fungal infection e.g. PCP, so give PCP prophylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What must be evaluated in history taking in a patient with suspected immune deficiency?

A

Clinical hx of infection + evidence: sputum cultures, response to abx

Alarm Sx for B cell malignancy

Hx for other illnesses: haematological malignancies, Hep B/C, TB

FH infection, AI, cancer

Medication hx

Vaccine hx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the front line chemical investigations for immune deficiency?

A

Renal + liver profile

Calcium + bone profile

Total protein + Albumin

Urine protein/ Cr ratio

Serum protein electrophoresis

Serum free light chains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What could cause isolated reduction in IgG?

A

Protein losing enteropathy

Prednisolone doses (cumulatively) >10mg/day

24
Q

What could cause a reduction in IgG and IgM?

A

B cell neoplasm

Hx of exposure to Rituximab

25
What could cause a reduction in IgG and IgA?
Primary antibody deficiency
26
What are monoclonal proteins associated with?
Multiple myeloma (IgG + IgA) WMG (IgM) NHL MGUS
27
How can SPE sometimes not detect multiple myeloma?
Some myeloma neoplasms just secrete light chains which are freely excreted into the urine so won't be detected on SPE SPE shows combination of heavy + light Measurement of FLC in urine or serum essential
28
If concentrations of vaccine antibodies are low, what should be done?
Offer test immunisation with Pneumovax II + tetanus Failure to respond to vaccination is part of diagnostic criteria for numerous primary antibody deficiency syndromes + for receipt of IgG replacement therapy
29
Why are vaccine antibody concentrations measured in the work up for immune deficiencies?
Tetanus: most of the UK have tetanus toxoid Indirect marker of how well T cells speak to B cells to make antibodies Pneumovax: T cell independent analysis of antibody production
30
What is the criteria for IgG replacement therapy?
Underlying cause of hypogammaglobinaemia irreversible or CI OR Hypogammaglobinaemia a/w drugs, therapeutic monoclonal antibodies targeted at B cells + plasma cells, post-HSCT, NHL, CLL, MM AND Recurrent/ severe bacterial infection despite continuous oral prophylaxis for 6m IgG \<4 Failure of vaccine response to unconjugated pneumococcal vaccine challenge
31
Give 4 features of HIV virology
4 lineages M, N, O, P (M most common) Slow evolution Double stranded RNA Retrovirus
32
Describe the replication of HIV virus
Binds to CD4 + then to chemokine co-receptor CCR5 or CXCR4 Replicates via a DNA intermediate Integrates into host genome HIV DNA transcribed to viral mRNA Viral RNA translated to viral proteins Packaging + release of mature virus
33
Describe the natural history of HIV as defined by viral replication
Acute: Flu-like illness in 70%, viral load peaks then dips after 3-6m to a set point Asymptomatic but progressive: Quiescent for 8-10y AIDS: increase in viral replication as immune system collapses
34
Describe the risk of transmission through the natural history of HIV
Directly proportional to amount of virus in blood Lots of transmission often in acute phase Risk of transmission declines in asymptomatic, though more people in this category Risk increases again but when pt is v sick
35
Why must combination therapy be used to treat HIV?
HIV not very good at replicating itself- huge no. of variants Short generation time + long duration of infection With progression of disease, get increased viral diversity so need to target different stages of the viral life cycle to reduce risk of drug resistance
36
Why do patients with HIV need to take lifelong antivirals?
Integration of HIV provirus into memory CD4 T cells within 72h of infection leads to formation of long lived reservoir of latent infection which doesn't respond to current ART
37
Describe the T cell immunology in natural HIV infection
Dip in CD4 T cells in blood Some partially recover Slow decline 8-10y Rapid decline when in AIDS phase
38
Describe the CD4 T cell count in the mucosa in HIV infection
Profound depletion of CD4 T cells Dont really receover Dissociation between counts in blood vs tissues
39
What is the immune deficiency often linked to in HIV?
Immune system not responding properly to immune activation With acute infection get increase in immune activation- generating a pro-inflammatory response Capacity to make new CD4 T cells reduces with progressive infection
40
Describe the humoral immunology in HIV infection
Acute: IgM to envelope protein gp41 + Gag Later ~12w: neutralising antibodies with capacity to prevent viral infection of that strain- but virus will have mutated
41
Describe how viral load differs depending on humoral response to HIV infection
Good B cell response: antibodies inhibiting replication by phagocytosis, fixation of complement. Bring down viral load Poor/ ineffective antibodies: have high viral load set point, doesn't vary over asymptomatic phase. Make antibodies targeting conserved parts of the HIV envelope- broadly neutralising antibodies
42
List 5 features of untreated HIV immunology
CD4 T cell depletion Chronic immune activation Impairment of CD4 + CD8 T cell function Disruption of lymph node architecture + impaired ability to generate protective T + B cell immune responses Loss of antigen-specific humoral immune responses: tetanus vaccine + alloimmune responses
43
What happens to the immune system in acute HIV?
Significant increase in HIV viral load in blood Significant risk of viral transmission Transient reduction in blood CD4 T cells Increase in CD8 T cell immune response coinciding with drop in VL CD8 T cell activation Induction of HIV specific antibodies
44
What tests can be used to diagnose HIV?
4th gen combined antigen/ antibody tests: 1m post acquisition Rapid POC: results in \<20mins less sensitive RNA tests when serological tests are -ve but high clinical suspicion of acute infection RNA/ DNA tests for kids \<18m
45
What baseline investigations should be performed in HIV?
FBC Renal, liver, bone, lipid profile, HbA1c Sexual health screen Screen for latent TB using IGRA CXR + ECG Toxoplasma serology
46
Which HIV specific tests need to be performed?
HIV viral load HIV genotype for ART drug resistance HIV tropism test to confirm co-receptor use (potential for CCR5 antagonists) HLA-B\*5701 to avoid Abacavir + risk of hypersensitivity reaction SJS/TEN CD4 T cell count + % CD4: CD8 T cell ratio
47
What is viral load set point correlated with? What is the magnitude influenced by?
Long term outcome Viral genotype CD8 T cell immune response Host genetics (HLA + CCR5) Immune activation
48
Give examples of infections seen at different cell counts in HIV
500: bacterial/ fungal skin infection, HSV, HZV 400: Kaposi sarcoma 300: TB 200: PCP 100: Toxoplasmosis, CMV, EBV brain lymphoma 75: Mycobacterium avium complex (MAC)
49
How does kaposi and TB infection differ depending ono cell count?
Good: Pulmonary TB ~400: Cutaneous Kaposi sarcoma Low: Miliary TB ~50: Kaposi affecting lungs + GIT
50
Which drugs can be used as part of antiretroviral therapy?
NRTI NNRTI Protease inhibitors Integrase inhibitors
51
How does ART work in HIV?
Prevents new cells being infected but can't eliminate infection once HIV has integrated into hist DNA
52
What happens if ART is stopped?
HIV replication re-commences + will be detectable in blood 2-3w later
53
Does ART change chronic immune inflammation?
No, does not reverse chronic immune inflammation This is a RF for cardiovascular, liver, bone + CNS disease
54
What needs to be monitored in patients with HIV?
Compliance with drug therapy + any SEs Viral load every 6m Potential liver, renal, bone + lipid toxicity Cardiovascular + osteoporosis risk Sexual health + vaccine uptake
55
What is the concept of the shock and kill strategy?
Shock: drugs reactivate latent HIV in CD4 infected T cells Kill: activated NK or CD8 T cells eliminate HIV infected cells Continue ART to prevent infection of new cells
56
What are broadly neutralising antibodies?
Neutralise multiple strains: bind to conserved envelope epitopes In 1-30% of patients May also activate other immune cells to help destroy HIV infected cells